Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2014 May 28;9(5):e97340.
doi: 10.1371/journal.pone.0097340. eCollection 2014.

Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission

Alison J Rodger  1 , Andrew Phillips  1 , Andrew Speakman  1 , Richard Gilson  1 , Martin Fisher  2 , Ed Wilkins  3 , Jane Anderson  4 , Margaret Johnson  5 , Rebecca O'Connell  6 , Simon Collins  7 , Jonathan Elford  8 , Lorraine Sherr  1 , Fiona C Lampe  1 ; ASTRA (Antiretrovirals, Sexual Transmission Risk and Attitudes) Study Group
Affiliations
Multicenter Study

Attitudes of people in the UK with HIV who Are Antiretroviral (ART) Naïve to starting ART at high CD4 counts for potential health benefit or to prevent HIV transmission

Alison J Rodger et al. PLoS One. .

Abstract

Objective: To assess if a strategy of early ART to prevent HIV transmission is acceptable to ART naïve people with HIV with high CD4 counts.

Design: ASTRA is a UK multicentre, cross sectional study of 3258 HIV outpatients in 2011/12. A self-completed questionnaire collected sociodemographic, behavioral and health data, and attitudes to ART; CD4 count was recorded from clinical records.

Methods: ART naïve participants with CD4 ≥350 cells/µL (n = 281) were asked to agree/disagree/undecided with the statements (i) I would want to start treatment now if this would slightly reduce my risk of getting a serious illness, and (ii) I would want to start treatment now if this would make me less infectious to a sexual partner, even if there was no benefit to my own health.

Results: Participants were 85% MSM, 76% white, 11% women. Of 281 participants, 49.5% and 45.2% agreed they would start ART for reasons (i) and (ii) respectively; 62.6% agreed with either (i) or (ii); 12.5% agreed with neither; 24.9% were uncertain. Factors independently associated (p<0.1) with agreement to (i) were: lower CD4, more recent HIV diagnosis, physical symptoms, not being depressed, greater financial hardship, and with agreement to (ii) were: being heterosexual, more recent HIV diagnosis, being sexually active.

Conclusions: A strategy of starting ART at high CD4 counts is likely to be acceptable to the majority of HIV-diagnosed individuals. Almost half with CD4 >350 would start ART to reduce infectiousness, even if treatment did not benefit their own health. However a significant minority would not like to start ART either for modest health benefit or to reduce infectivity. Any change in approach to ART initiation must take account of individual preferences. Transmission models of potential benefit of early ART should consider that ART uptake may be lower than that seen with low CD4 counts.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Attitudes to early ART among 281 ART naïve individuals with CD4 ≥350 cells/µL.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. http://europeanaidsclinicalsociety.org/images/stories/EACS-Pdf/EacsGuide.... Accessed 2013 Nov 14.
    1. Williams I, Churchill D, Anderson J, Boffito M, Bower M, et al. (2012) British HIV Association Guidelines for the Treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med 13 (Suppl 2) 1–85. - PubMed
    1. Hirnschall G, Harries AD, Easterbrook PJ, Doherty MC, Ball A, et al. (2013) The next generation of the World Health Organization's global antiretroviral guidance. J Int AIDS 30;16: 18757. - PMC - PubMed
    1. US Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available: http://aidsinfo.nih.gov/guidelines. Accessed 2013 Nov 14.
    1. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, et al. (2012) Antiretroviral treatment of adult HIV infection. 2012 Recommendations of the International Antiviral Society – USA Panel. JAMA 308: 387–402. - PubMed

Publication types

Substances